Risk Minimisation Study for Diane-35 and Its Generics

Overview

The study will be an observational, cross-sectional study of knowledge, understanding, and self-reported behavior among a sample of physicians with recent experience in prescribing Diane-35 or its generics in a total of five European countries. The primary objective of this study is to measure physician knowledge and understanding of the key information contained in the Diane-35 educational material: Patient information card, and Prescribers' Checklist. Specifically, the following objectives will be addressed: * Investigate whether physicians have received any educational material related to Diane-35 or its generics * Assess physicians' knowledge and understanding of key safety information pertaining to the patient information card * Assess physicians' knowledge and understanding of key safety information pertaining to the following areas: * Contraindications relevant to thromboembolism * Risk factors for thromboembolism * Signs and symptoms of thromboembolism

Conditions

Interventions